Page last updated: 2024-08-24

1,2-distearoyllecithin and B16 Melanoma

1,2-distearoyllecithin has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berlin Grace, VM; Reji, RM; Sundaram, V	1

Other Studies

1 other study(ies) available for 1,2-distearoyllecithin and B16 Melanoma

Article	Year
Enhanced expression of tumour suppressor RAR-β by DSPC nano-formulated lipo-ATRA in the lung of B16F10 cell-implanted C57BL6 mice and in A549 cells. Life sciences, 2017, Sep-01, Volume: 184 Topics: A549 Cells; Animals; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tretinoin	2017

Article

Year

Enhanced expression of tumour suppressor RAR-β by DSPC nano-formulated lipo-ATRA in the lung of B16F10 cell-implanted C57BL6 mice and in A549 cells.

Life sciences, 2017, Sep-01, Volume: 184

Topics: A549 Cells; Animals; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tretinoin

2017